564 related articles for article (PubMed ID: 35116071)
21. Predictions of the dysregulated competing endogenous RNA signature involved in the progression of human lung adenocarcinoma.
Yang D; He Y; Wu B; Liu R; Wang N; Wang T; Luo Y; Li Y; Liu Y
Cancer Biomark; 2020; 29(3):399-416. PubMed ID: 32741804
[TBL] [Abstract][Full Text] [Related]
22. Loss of circadian clock gene expression is associated with tumor progression in breast cancer.
Cadenas C; van de Sandt L; Edlund K; Lohr M; Hellwig B; Marchan R; Schmidt M; Rahnenführer J; Oster H; Hengstler JG
Cell Cycle; 2014; 13(20):3282-91. PubMed ID: 25485508
[TBL] [Abstract][Full Text] [Related]
23. Investigating gene signatures associated with immunity in colon adenocarcinoma to predict the immunotherapy effectiveness using NFM and WGCNA algorithms.
Liang W; Yang X; Li X; Wang P; Zhu Z; Liu S; Xu D; Zhi X; Xue J
Aging (Albany NY); 2024 May; 16(9):7596-7621. PubMed ID: 38742936
[TBL] [Abstract][Full Text] [Related]
24. Integration analysis for novel lncRNA markers predicting tumor recurrence in human colon adenocarcinoma.
Chen F; Li Z; Deng C; Yan H
J Transl Med; 2019 Aug; 17(1):299. PubMed ID: 31470869
[TBL] [Abstract][Full Text] [Related]
25. Identification of prognostic biomarkers and drug target prediction for colon cancer according to a competitive endogenous RNA network.
Hu D; Zhang B; Yu M; Shi W; Zhang L
Mol Med Rep; 2020 Aug; 22(2):620-632. PubMed ID: 32468035
[TBL] [Abstract][Full Text] [Related]
26. Developing a RiskScore Model based on Angiogenesis-related lncRNAs for Colon Adenocarcinoma Prognostic Prediction.
Li X; Lei J; Shi Y; Peng Z; Gong M; Shu X
Curr Med Chem; 2024; 31(17):2449-2466. PubMed ID: 37961859
[TBL] [Abstract][Full Text] [Related]
27. Construction and Validation of Pyroptosis-Related lncRNA Prediction Model for Colon Adenocarcinoma and Immune Infiltration Analysis.
Liu Q; Chen N; Liu L; Zheng Q; Liao W; Zhao M; Zeng J; Tang J
Dis Markers; 2022; 2022():4492608. PubMed ID: 36168326
[TBL] [Abstract][Full Text] [Related]
28. An Intratumor Heterogeneity-Related Signature for Predicting Prognosis, Immune Landscape, and Chemotherapy Response in Colon Adenocarcinoma.
Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Zhou F; Xie Y
Front Med (Lausanne); 2022; 9():925661. PubMed ID: 35872794
[TBL] [Abstract][Full Text] [Related]
29. Identification prognosis-associated immune genes in colon adenocarcinoma.
Miao Y; Wang J; Ma X; Yang Y; Mi D
Biosci Rep; 2020 Nov; 40(11):. PubMed ID: 33140821
[TBL] [Abstract][Full Text] [Related]
30. Research on circadian clock genes in common abdominal malignant tumors.
Qiu MJ; Liu LP; Jin S; Fang XF; He XX; Xiong ZF; Yang SL
Chronobiol Int; 2019 Jul; 36(7):906-918. PubMed ID: 31014126
[TBL] [Abstract][Full Text] [Related]
31. Comprehensive analysis of microRNA/mRNA signature in colon adenocarcinoma.
Wang JY; Wang CL; Wang XM; Liu FJ
Eur Rev Med Pharmacol Sci; 2017 May; 21(9):2114-2129. PubMed ID: 28537673
[TBL] [Abstract][Full Text] [Related]
32. Contributions of Gene Modules Regulated by Essential Noncoding RNA in Colon Adenocarcinoma Progression.
Li C; Yu X; Lu J; Zheng L; Xu D; Xu Z; Wang L; Cui Y; Li Y; Wang H; Xu J; Li K
Biomed Res Int; 2020; 2020():8595473. PubMed ID: 32280704
[TBL] [Abstract][Full Text] [Related]
33. Identification of the Prognostic Value and Clinical Significance of Interferon Regulatory Factors (IRFs) in Colon Adenocarcinoma.
Yuemaier M; Zhou Z; Zhou Y; Wu C; Li F; Liang X; Kang H; Shen D; Gao F; Lin J
Med Sci Monit; 2020 Nov; 26():e927073. PubMed ID: 33161410
[TBL] [Abstract][Full Text] [Related]
34. Pan-Cancer Analysis Reveals Disrupted Circadian Clock Associates With T Cell Exhaustion.
Wu Y; Tao B; Zhang T; Fan Y; Mao R
Front Immunol; 2019; 10():2451. PubMed ID: 31708917
[TBL] [Abstract][Full Text] [Related]
35. Prediction and identification of immune genes related to the prognosis of patients with colon adenocarcinoma and its mechanisms.
Chen S; Cao GD; Wei W; Yida L; Xiaobo H; Lei Y; Ke C; Chen B; Xiong MM
World J Surg Oncol; 2020 Jun; 18(1):146. PubMed ID: 32600423
[TBL] [Abstract][Full Text] [Related]
36. A Pyroptosis-Related Gene Signature to Predict Patients' Prognosis and Immune Landscape in Liver Hepatocellular Carcinoma.
Wang J; Huang Z; Lu H; Zhang R; Feng Q; He A
Comput Math Methods Med; 2022; 2022():1258480. PubMed ID: 35242200
[TBL] [Abstract][Full Text] [Related]
37. Identification of hub genes and construction of transcriptional regulatory network for the progression of colon adenocarcinoma hub genes and TF regulatory network of colon adenocarcinoma.
Wei S; Chen J; Huang Y; Sun Q; Wang H; Liang X; Hu Z; Li X
J Cell Physiol; 2020 Mar; 235(3):2037-2048. PubMed ID: 31612481
[TBL] [Abstract][Full Text] [Related]
38. Diagnostic and prognostic values of integrin α subfamily mRNA expression in colon adenocarcinoma.
Gong YZ; Ruan GT; Liao XW; Wang XK; Liao C; Wang S; Gao F
Oncol Rep; 2019 Sep; 42(3):923-936. PubMed ID: 31322253
[TBL] [Abstract][Full Text] [Related]
39. LINC00342 regulates cell proliferation, apoptosis, migration and invasion in colon adenocarcinoma via miR-545-5p/MDM2 axis.
Miao Z; Liu S; Xiao X; Li D
Gene; 2020 Jun; 743():144604. PubMed ID: 32213297
[TBL] [Abstract][Full Text] [Related]
40. Identification of a glycolysis- and lactate-related gene signature for predicting prognosis, immune microenvironment, and drug candidates in colon adenocarcinoma.
Liu C; Liu D; Wang F; Xie J; Liu Y; Wang H; Rong J; Xie J; Wang J; Zeng R; Zhou F; Peng J; Xie Y
Front Cell Dev Biol; 2022; 10():971992. PubMed ID: 36081904
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
